|
1
|
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.
|
Lancet
|
2015
|
3.79
|
|
2
|
Monitoring cholesterol levels: measurement error or true change?
|
Ann Intern Med
|
2008
|
3.35
|
|
3
|
Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.
|
Diabetes Care
|
2003
|
2.82
|
|
4
|
Effect of pravastatin on cardiovascular events in people with chronic kidney disease.
|
Circulation
|
2004
|
2.33
|
|
5
|
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.
|
Heart Lung Circ
|
2005
|
2.16
|
|
6
|
Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease.
|
Circulation
|
2005
|
2.13
|
|
7
|
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
|
Arch Intern Med
|
2004
|
1.69
|
|
8
|
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project.
|
Circulation
|
2002
|
1.51
|
|
9
|
Why did high-dose rosuvastatin not improve cardiac remodeling in chronic heart failure? Mechanistic insights from the UNIVERSE study.
|
Int J Cardiol
|
2010
|
1.48
|
|
10
|
Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE).
|
Drugs Aging
|
2003
|
1.47
|
|
11
|
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
|
Eur Heart J
|
2004
|
1.46
|
|
12
|
Accumulation of microplastic on shorelines woldwide: sources and sinks.
|
Environ Sci Technol
|
2011
|
1.44
|
|
13
|
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
|
Circulation
|
2002
|
1.43
|
|
14
|
Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction.
|
Cochrane Database Syst Rev
|
2015
|
1.41
|
|
15
|
Dose-dependent effects of folic acid on plasma homocysteine in a randomized trial conducted among 723 individuals with coronary heart disease.
|
Eur Heart J
|
2002
|
1.40
|
|
16
|
Nursing sans frontières: a three year case study of multi-state registration to support nursing practice using information technology.
|
Aust J Adv Nurs
|
2006
|
1.39
|
|
17
|
Primary health care research--essential but disadvantaged.
|
Med J Aust
|
2006
|
1.35
|
|
18
|
Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003.
|
Drug Saf
|
2007
|
1.31
|
|
19
|
Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study.
|
Aust N Z J Public Health
|
2003
|
1.25
|
|
20
|
Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study.
|
BMC Public Health
|
2010
|
1.16
|
|
21
|
Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis.
|
J Am Coll Cardiol
|
2011
|
1.16
|
|
22
|
Comparative effectiveness of population interventions to improve access to reperfusion for ST-segment-elevation myocardial infarction in Australia.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
1.14
|
|
23
|
Why do phase III trials of promising heart failure drugs often fail? The contribution of "regression to the truth".
|
J Card Fail
|
2003
|
1.10
|
|
24
|
Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design.
|
Am Heart J
|
2007
|
1.06
|
|
25
|
Familial hypercholesterolaemia: a model of care for Australasia.
|
Atheroscler Suppl
|
2011
|
1.04
|
|
26
|
Association between impaired glucose metabolism and quality of life: results from the Australian diabetes obesity and lifestyle study.
|
Diabetes Res Clin Pract
|
2006
|
1.02
|
|
27
|
Effect of pravastatin in people with diabetes and chronic kidney disease.
|
J Am Soc Nephrol
|
2005
|
1.02
|
|
28
|
Population trends of recurrent coronary heart disease event rates remain high.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
0.98
|
|
29
|
Rheumatic heart disease in indigenous populations.
|
Heart Lung Circ
|
2010
|
0.97
|
|
30
|
Age-specific trends in cardiovascular mortality rates in the Netherlands between 1980 and 2009.
|
Eur J Epidemiol
|
2011
|
0.96
|
|
31
|
What becomes of the broken hearted? Coronary heart disease as a paradigm of cardiovascular disease and poor health among indigenous australians.
|
Heart Lung Circ
|
2005
|
0.93
|
|
32
|
Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.
|
J Card Fail
|
2007
|
0.93
|
|
33
|
Outdoor air pollution as a trigger for out-of-hospital cardiac arrests.
|
Epidemiology
|
2010
|
0.93
|
|
34
|
Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst indigenous and non indigenous people at high cardiovascular risk.
|
BMC Public Health
|
2010
|
0.93
|
|
35
|
Inequalities in cardiovascular disease mortality: the role of behavioural, physiological and social risk factors.
|
J Epidemiol Community Health
|
2009
|
0.93
|
|
36
|
Adherence, adaptation and acceptance of elderly chronic heart failure patients to receiving healthcare via telephone-monitoring.
|
Eur J Heart Fail
|
2007
|
0.89
|
|
37
|
Building better systems of care for Aboriginal and Torres Strait Islander people: findings from the Kanyini health systems assessment.
|
BMC Health Serv Res
|
2012
|
0.89
|
|
38
|
Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study.
|
J Am Heart Assoc
|
2013
|
0.89
|
|
39
|
Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
|
Am Heart J
|
2003
|
0.88
|
|
40
|
Parametric conditional frailty models for recurrent cardiovascular events in the lipid study.
|
Clin Trials
|
2008
|
0.87
|
|
41
|
A systematic review of air pollution and incidence of out-of-hospital cardiac arrest.
|
J Epidemiol Community Health
|
2013
|
0.87
|
|
42
|
Evaluating the impact of air pollution on the incidence of out-of-hospital cardiac arrest in the Perth Metropolitan Region: 2000-2010.
|
J Epidemiol Community Health
|
2013
|
0.85
|
|
43
|
Coronary disease in indigenous populations: summary from the CSANZ indigenous Cardiovascular Health Conference.
|
Heart Lung Circ
|
2010
|
0.84
|
|
44
|
Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study.
|
Med J Aust
|
2008
|
0.84
|
|
45
|
Discordant age and sex-specific trends in the incidence of a first coronary heart disease event in Western Australia from 1996 to 2007.
|
Heart
|
2011
|
0.83
|
|
46
|
Best practice for prevention and treatment of cardiovascular disease through an equity lens: a review.
|
Eur J Cardiovasc Prev Rehabil
|
2010
|
0.83
|
|
47
|
Nurse-led titration of β-adrenoreceptor blocking agents in chronic heart failure patients in the community.
|
J Card Fail
|
2010
|
0.82
|
|
48
|
Accuracy of national mortality codes in identifying adjudicated cardiovascular deaths.
|
Aust N Z J Public Health
|
2011
|
0.82
|
|
49
|
Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion).
|
BMC Neurol
|
2012
|
0.81
|
|
50
|
Chronic heart failure--optimising care in general practice.
|
Aust Fam Physician
|
2005
|
0.81
|
|
51
|
Associations among smoking status, lifestyle and lipoprotein subclasses.
|
J Clin Lipidol
|
2010
|
0.80
|
|
52
|
Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study.
|
Atherosclerosis
|
2005
|
0.80
|
|
53
|
High platelet reactivity and antiplatelet therapy resistance.
|
Semin Thromb Hemost
|
2012
|
0.80
|
|
54
|
Bush telegraph. Improving outcomes for rural and remote patients with chronic heart failure.
|
Aust Fam Physician
|
2004
|
0.79
|
|
55
|
Telephone support to rural and remote patients with heart failure: the Chronic Heart Failure Assessment by Telephone (CHAT) study.
|
Cardiovasc Ther
|
2013
|
0.78
|
|
56
|
Improving cardiovascular care for indigenous populations.
|
Heart Lung Circ
|
2010
|
0.78
|
|
57
|
Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study.
|
Eur J Cardiovasc Prev Rehabil
|
2009
|
0.78
|
|
58
|
Effects of the vasopeptidase inhibitor, omapatrilat, in 723 patients with coronary heart disease.
|
J Renin Angiotensin Aldosterone Syst
|
2002
|
0.78
|
|
59
|
Overview and determinants of cardiovascular disease in indigenous populations.
|
Heart Lung Circ
|
2010
|
0.77
|
|
60
|
Statins in the elderly: an answered question?
|
Curr Opin Cardiol
|
2014
|
0.77
|
|
61
|
Complexity of management and health outcomes in a prospective cohort study of 573 heart failure patients in Australia: does more equal less?
|
J Clin Nurs
|
2013
|
0.77
|
|
62
|
Psychometric properties of the cardiac depression scale in patients with coronary heart disease.
|
BMC Psychiatry
|
2012
|
0.77
|
|
63
|
Semi-parametric risk prediction models for recurrent cardiovascular events in the LIPID study.
|
BMC Med Res Methodol
|
2010
|
0.77
|
|
64
|
Secondary prevention of CHD.
|
Aust Fam Physician
|
2005
|
0.77
|
|
65
|
Long term safety of statins should be monitored.
|
BMJ
|
2006
|
0.76
|
|
66
|
The Cardiac Society Inaugural Cardiovascular Health Conference: conference findings and ways forward.
|
Heart Lung Circ
|
2010
|
0.76
|
|
67
|
Comparison of the effects of pravastatin and atorvastatin on fracture incidence in the PROVE IT-TIMI 22 trial--secondary analysis of a randomized controlled trial.
|
Bone
|
2005
|
0.76
|
|
68
|
Recommendations arising from the inaugural CSANZ Conference on Indigenous Cardiovascular Health.
|
Heart Lung Circ
|
2010
|
0.75
|
|
69
|
Put disease prevention first.
|
Circulation
|
2013
|
0.75
|
|
70
|
A meta-analysis of the effect of thiazolidinediones on in-stent restenosis after coronary stent implantation.
|
Am Heart J
|
2007
|
0.75
|
|
71
|
The MAGIC Study and the gastrointestinal effects of low-dose aspirin : editorial to: "Prospective cohort study of gastrointestinal complications and vascular diseases in patients taking aspirin: rationale and design of the MAGIC Study" by H. Origasa et al.
|
Cardiovasc Drugs Ther
|
2011
|
0.75
|
|
72
|
Reply: the latest generation of troponin immunoassays: the "cholesterol" of the third millennium?
|
J Am Coll Cardiol
|
2014
|
0.75
|
|
73
|
Increased psychosocial stress in Greek-born immigrants compared to Anglo-Australians with coronary heart disease: the healthy heart, healthy mind study.
|
Heart Lung Circ
|
2012
|
0.75
|
|
74
|
School food environment and nutrition policies in Southern Metropolitan schools in Melbourne.
|
Aust N Z J Public Health
|
2012
|
0.75
|
|
75
|
A new model of care for familial hypercholesterolaemia: what is the role of cardiology?
|
Heart Lung Circ
|
2012
|
0.75
|
|
76
|
Development of an evidence-based scoring system (HF-IS) to assess the quality of heart failure programmes for patients postdischarge from hospital.
|
J Clin Nurs
|
2011
|
0.75
|
|
77
|
CHAT--a study of a nurse-led system of care.
|
Aust Nurs J
|
2006
|
0.75
|
|
78
|
Relevancy of the National Heart Foundation.
|
Heart Lung Circ
|
2002
|
0.75
|
|
79
|
Cardiovascular medicine in the region--status report by the Asian-Pacific Society of Cardiology.
|
Asian Cardiovasc Thorac Ann
|
2002
|
0.75
|
|
80
|
Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohorts.
|
J Hypertens
|
2016
|
0.75
|
|
81
|
Obituary - Henry Krum.
|
Heart Lung Circ
|
2016
|
0.75
|